計算病理学市場規模、シェア、動向分析レポート：コンポーネント別、用途別、技術別、最終用途別、地域別、セグメント別予測、2025年～2030年

計算病理学市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の計算病理学市場規模は2030年までに10億4,000万米ドルに達し、2025～2030年のCAGRは8.24％を記録すると予測されています。

この成長は、慢性疾患の有病率の上昇、迅速な診断のための先進的ソリューションに対する需要の高まり、機械学習（ML）と人工知能（AI）技術の統合の高まり、先進的ソリューションの開発に注力する市場プレイヤが支援する医療への投資の増加に起因しています。

人工知能（AI）と機械学習（ML）アルゴリズムをデジタル病理ワークフローに統合することで、病理画像の迅速かつ正確な分析が可能になり、このセグメントに革命をもたらしています。AIを搭載したツールは、病理医がパターンを検出し、病気の進行を予測し、病気の発見に極めて重要な臨床的関連性のある洞察を得られるよう支援することができます。例えば、ペイジは2024年9月、個別化医療とプレシジョン・オンコロジーを変革することを目的とした臨床グレードのマルチモーダル・コパイロットであるペイジ・アルバを発表しました。Albaは、患者データからリアルタイムでAI主導洞察を提供し、これまでにないスピードと規模で臨床上の意思決定を強化します。このイノベーションは、医療における人工知能（AGI）への大きな飛躍を意味し、AIががんのような複雑な疾患の診断や治療において臨床医をサポートするだけでなく、臨床医と協働する未来に産業を近づけるものです。

同市場で事業を展開する複数の企業も、計算病理学の応用と性能を高める革新的ソリューションの開発に注力しています。例えば、2023年8月、Microsoftとペイジの研究開発は、計算病理学のための第2世代基盤モデルであるVirchow2とVirchow2Gを開発しました。これらの大規模な言語モデルは、臨床情報、病理所見、疾患の転帰の間の複雑な関係を理解するために、膨大な病理学的データに対して学習されます。

Virchow2とVirchow2Gは、人間が読めるテキストを生成し、質問に答え、レポート作成や症例要約などのタスクを支援することができます。これらのモデルは、特定のタスクに合わせて微調整できるように設計されており、様々な計算病理学アプリケーションで使用することができます。この進歩は、AIを活用して病理医の意思決定を強化し、計算病理学における患者ケアを改善する上で、大きな前進を意味します。同様に、従来型顕微鏡検査からデジタル病理検査への移行も市場成長にさらに貢献しています。この移行により、アクセシビリティが向上し、世界中の病理医の遠隔診察や共同作業が容易になります。

COVID-19の流行は、医療システムが安全プロトコルの遵守を確保しながら業務を遂行するための代替手段を模索する中で、この動向を加速させています。さらに、規制機関はデジタル病理学の成長に大きく貢献しており、さまざまなデジタル画像システムとソフトウェアアプリケーションの承認につながっています。組織がデジタルワークフローをサポートするためのインフラに投資するにつれて、業務効率の向上と診断能力の改善に基づき、市場は大きな成長を遂げることが予想されます。

計算病理学市場レポートハイライト

• コンポーネント別では、臨床ワークフローの強化に役立つこれらのソリューションが提供するさまざまな利点により、ソフトウェアセグメントが2024年の市場を独占しました。
• 用途別では、病院や診断センターでより効果的で正確な診断ツールに対する需要が世界的に高まっていることから、疾病診断が2024年の売上シェア45.7%で用途セグメントを独占。
• 技術別では、機械学習が2024年に市場を独占しました。これは、医療施設においてより優れた性能と結果を提供するML技術を統合した計算病理学ソリューションの開発台数が増加しているためです。
• 最終用途別では、病院と診断ラボセグメントが2024年に51.09％の最大市場シェアを占めました。
• 北米は2024年に40.5%の最大市場シェアを占めました。これは、同地域の医療インフラが発達し、がんなどの慢性疾患の罹患率の上昇と相まって、計算病理学ソリューションへのアクセスが増加していることに起因しています。
• 主要企業は、サービスポートフォリオを拡大し、地理的プレゼンスを強化するために、製品発売、提携、買収、合併などのさまざまな戦略を採用しており、市場内の大きな競合につながっています。例えば、2023年2月、クララパスはクロスコープを買収し、組織処理ロボットとAIを活用したデジタル病理を統合し、"未来のラボ"の実現を目指しています。この組み合わせは、先進的画像分析と診断のためにAI技術を活用しながら、組織処理を自動化することでワークフローの効率を高めています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 計算病理学市場の変数、動向、範囲

• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
• 計算病理学市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析
  • 新興技術の動向
  • COVID-19の影響分析
  • 使用事例分析

第4章 計算病理学市場：コンポーネント別、推定・動向分析

• コンポーネント市場シェア、2024年と2030年
• セグメントダッシュボード
• コンポーネントによる世界の計算病理学市場展望
• ソフトウェア
• サービス

第5章 計算病理学市場：用途別、推定・動向分析

• 用途市場シェア、2024年と2030年
• セグメントダッシュボード
• 用途による世界の計算病理学市場展望
• 病気の診断
• 医薬品の発見と開発
• 学術研究

第6章 計算病理学市場：技術別、推定・動向分析

• 技術市場シェア、2024年と2030年
• セグメントダッシュボード
• 技術による世界の計算病理学市場展望
• 機械学習（ML）
  • ディープラーニング
  • その他
• 自然言語処理（NLP）モデル
• コンピュータービジョン
• その他

第7章 計算病理学市場：最終用途別、推定・動向分析

• 最終用途市場シェア、2024年と2030年
• セグメントダッシュボード
• 最終用途による世界の計算病理学市場展望
• 病院と診断ラボ
• バイオテクノロジーと製薬会社
• 学術研究機関
• その他

第8章 計算病理学市場：地域推定・動向分析、コンポーネント別、用途別、技術別、最終用途別

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 世界地域市場のスナップショット
• 市場規模と予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• 主要企業の市場シェア/ポジション分析、2024年
• 企業プロファイル
  • Leica Biosystems Nussloch GmbH（Danaher）
  • Hamamatsu Photonics KK
  • Koninklijke Philips NV
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd.
  • Mikroscan Technologies, Inc.
  • Epredia（3DHISTECH Ltd.）
  • Visiopharm A/S
  • Proscia Inc.
  • Tempus
  • Huron Technologies International Inc.
  • ContextVision AB
  • CellaVision
  • aetherAI
  • CellCarta
  • IBEX（IBEX MEDICAL ANALYTICS）
  • Nucleai, Inc.

List of Tables

• Table 1 List of abbreviation
• Table 2 North America Computational Pathology Market, By Region, 2018 - 2030 (USD Million)
• Table 3 North America Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 4 North America Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 5 North America Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 6 North America Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 7 U.S. Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 8 U.S. Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 9 U.S. Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 10 U.S. Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 11 Canada Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 12 Canada Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 13 Canada Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 14 Canada Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 15 Mexico Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 16 Mexico Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 17 Mexico Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 18 Mexico Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 19 Europe Computational Pathology Market, By Region, 2018 - 2030 (USD Million)
• Table 20 Europe Computational Pathology Market, By Component, 2018 - 2030 (USD Million)
• Table 21 Europe Computational Pathology Market, By Technology, 2018 - 2030 (USD Million)
• Table 22 Europe Computational Pathology Market, By Application, 2018 - 2030 (USD Million)
• Table 23 Europe Computational Pathology Market, By End use, 2018 - 2030 (USD Million)
• Table 24 Germany Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 25 Germany Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 26 Germany Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 27 Germany Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 28 UK Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 29 UK Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 30 UK Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 31 UK Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 32 France Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 33 France Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 34 France Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 35 France Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 36 Italy Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 37 Italy Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 38 Italy Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 39 Italy Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 40 Spain Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 41 Spain Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 42 Spain Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 43 Spain Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 44 Denmark Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 45 Denmark Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 46 Denmark Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 47 Denmark Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 48 Sweden Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 49 Sweden Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 50 Sweden Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 51 Sweden Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 52 Norway Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 53 Norway Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 54 Norway Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 55 Norway Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific Computational Pathology Market, by region, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 61 China Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 62 China Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 63 China Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 64 China Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 65 Japan Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 66 Japan Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 67 Japan Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 68 Japan Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 69 India Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 70 India Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 71 India Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 72 India Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 73 South Korea Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 74 South Korea Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 75 South Korea Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 76 South Korea Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 77 Australia Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 78 Australia Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 79 Australia Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 80 Australia Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 81 Thailand Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 82 Thailand Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 83 Thailand Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 84 Thailand Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 85 Latin America Computational Pathology Market, by region, 2018 - 2030 (USD Million)
• Table 86 Latin America Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 87 Latin America Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 88 Latin America Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 89 Latin America Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 90 Brazil Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 91 Brazil Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 92 Brazil Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 93 Brazil Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 94 Argentina Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 95 Argentina Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 96 Argentina Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 97 Argentina Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 98 MEA Computational Pathology Market, by region, 2018 - 2030 (USD Million)
• Table 99 MEA Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 100 MEA Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 101 MEA Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 102 MEA Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 103 South Africa Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 104 South Africa Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 105 South Africa Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 106 South Africa Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 110 Saudi Arabia Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 111 UAE Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 112 UAE Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 113 UAE Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 114 UAE Computational Pathology Market By End use, 2018 - 2030 (USD Million)
• Table 115 Kuwait Computational Pathology Market, 2018 - 2030 (USD Million)
• Table 116 Kuwait Computational Pathology Market By Component, 2018 - 2030 (USD Million)
• Table 117 Kuwait Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
• Table 118 Kuwait Computational Pathology Market By Application, 2018 - 2030 (USD Million)
• Table 119 Kuwait Computational Pathology Market By End use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Computational Pathology Market outlook
• Fig. 9 Computational Pathology competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 Computational Pathology Market driver impact
• Fig. 15 Computational Pathology Market restraint impact
• Fig. 16 Computational Pathology Market strategic initiatives analysis
• Fig. 17 Computational Pathology Market: Component movement analysis
• Fig. 18 Computational Pathology Market: Component outlook and key takeaways
• Fig. 19 Software market estimates and forecast, 2018 - 2030
• Fig. 20 Services market estimates and forecast, 2018 - 2030
• Fig. 21 Computational Pathology Market: Application movement analysis
• Fig. 22 Computational Pathology Market: Application outlook and key takeaways
• Fig. 23 Disease diagnosis market estimates and forecast, 2018 - 2030
• Fig. 24 Drug discovery & development market estimates and forecast, 2018 - 2030
• Fig. 25 Academic research market estimates and forecast, 2018 - 2030
• Fig. 26 Computational Pathology Market: Technology movement analysis
• Fig. 27 Computational Pathology Market: Technology outlook and key takeaways
• Fig. 28 Machine Learning (ML) market estimates and forecast, 2018 - 2030
• Fig. 29 Deep Learning market estimates and forecast, 2018 - 2030
• Fig. 30 Others market estimates and forecast, 2018 - 2030
• Fig. 31 Natural Language Processing (NLP) models market estimates and forecast, 2018 - 2030
• Fig. 32 Computer vision market estimates and forecast, 2018 - 2030
• Fig. 33 Others market estimates and forecast, 2018 - 2030
• Fig. 34 Computational Pathology Market: End use movement analysis
• Fig. 35 Computational Pathology Market: End use outlook and key takeaways
• Fig. 36 Hospitals and Diagnostic Labs market estimates and forecast, 2018 - 2030
• Fig. 37 Biotechnology and Pharmaceutical Companies market estimates and forecast, 2018 - 2030
• Fig. 38 Academic and Research Institutes market estimates and forecast, 2018 - 2030
• Fig. 39 Other market estimates and forecast, 2018 - 2030
• Fig. 40 Global Computational Pathology Market: Regional movement analysis
• Fig. 41 Global Computational Pathology Market: Regional outlook and key takeaways
• Fig. 42 Global Computational Pathology Market share and leading players
• Fig. 43 North America market share and leading players
• Fig. 44 Europe market share and leading players
• Fig. 45 Asia Pacific market share and leading players
• Fig. 46 Latin America market share and leading players
• Fig. 47 Middle East & Africa market share and leading players
• Fig. 48 North America market estimates and forecasts, 2018 - 2030
• Fig. 49 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 50 Canada market estimates and forecasts, 2018 - 2030
• Fig. 51 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 52 Europe market estimates and forecasts, 2018 - 2030
• Fig. 53 UK market estimates and forecasts, 2018 - 2030
• Fig. 54 Germany market estimates and forecasts, 2018 - 2030
• Fig. 55 France market estimates and forecasts, 2018 - 2030
• Fig. 56 Italy market estimates and forecasts, 2018 - 2030
• Fig. 57 Spain market estimates and forecasts, 2018 - 2030
• Fig. 58 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 59 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 60 Norway market estimates and forecasts, 2018 - 2030
• Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 62 China market estimates and forecasts, 2018 - 2030
• Fig. 63 Japan market estimates and forecasts, 2018 - 2030
• Fig. 64 India market estimates and forecasts, 2018 - 2030
• Fig. 65 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 66 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 67 Australia market estimates and forecasts, 2018 - 2030
• Fig. 68 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 69 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 70 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 71 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 72 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 73 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 74 UAE market estimates and forecasts, 2018 - 2030
• Fig. 75 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 76 Market share of key market players- Computational Pathology Market
• Fig. 77 Key Company Categorization
• Fig. 78 Company Market Share/Position Analysis, 2024
• Fig. 79 Strategic Framework

Computational Pathology Market Growth & Trends:

The global computational pathology market size is expected to reach USD 1.04 billion by 2030, registering a CAGR of 8.24% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising prevalence of chronic diseases, the increasing demand for advanced solutions for faster diagnosis, the rising integration of Machine Learning (ML) and artificial intelligence (AI) technologies and increasing investment in healthcare supported by market players focused on developing advanced solutions.

Integrating artificial intelligence (AI) and machine learning (ML) algorithms into digital pathology workflows is revolutionizing the field, enabling faster and more accurate analysis of pathology images. AI-powered tools can assist pathologists in detecting patterns, predicting disease progression, and giving clinically relevant insights crucial for disease detection. For instance, In September 2024, Paige introduced Paige Alba, a clinical-grade multimodal co-pilot aimed at transforming personalized medicine and precision oncology. Alba provides real-time, AI-driven insights from patient data, enhancing clinical decision-making at unprecedented speed and scale. This innovation represents a major leap toward Artificial General Intelligence (AGI) in healthcare, bringing the industry closer to a future where AI not only supports but collaborates with clinicians in diagnosing and treating complex diseases such as cancer.

Several companies operating in the market also focusing on developing innovative solutions to enhance the application and performance of computational pathology. For instance, in August 2023, Microsoft and Paige researchers developed Virchow2 and Virchow2G, second-generation foundation models for computational pathology. These large language models are trained on vast amounts of pathology data to understand the complex relationships between clinical information, pathology findings, and disease outcomes.

Virchow2 and Virchow2G can generate human-readable text, answer questions, and assist in tasks like report generation and case summarization. The models are designed to be fine-tuned for specific tasks, enabling their use in various computational pathology applications. This advancement represents a significant step forward in leveraging AI to enhance pathologists' decision-making and improve patient care in computational pathology. Similarly, transitioning from traditional microscopy to digital pathology further contributes to the market growth. This shift enhances accessibility and facilitates remote consultations and collaborative efforts among pathologists worldwide.

The COVID-19 pandemic has accelerated this trend as healthcare systems search for alternatives to execute operations while ensuring compliance with safety protocols. Furthermore, regulatory bodies significantly contribute to digital pathology's growth, leading to approvals for various digital imaging systems and software applications. As organizations invest in infrastructure to support digital workflows, the market is expected to witness significant growth driven by enhanced operational efficiencies and improved diagnostic capabilities.

Computational Pathology Market Report Highlights:

• Based on component, software segment dominated the market in 2024 owing to the various advantages offered by these solutions that help in enhancing clinical workflows.
• Based on application, disease diagnosis dominated the application segment with a revenue share of 45.7% in 2024 owing to the rising demand for more effective and accurate diagnosis tools in hospitals and diagnostics centers globally.
• Based on technology, machine learning dominated the market in 2024 owing to the rising development of computational pathology solutions with integrated ML technologies that offer better performance and outcomes in healthcare facilities.
• Based on end use, hospitals and diagnostic labs segment held the largest market share of 51.09% in 2024, driven by the increasing demand for advanced diagnostic tools and efficient workflow solutions.
• North America held the largest market share of 40.5% in 2024. This can be attributed to the regions developed healthcare infrastructure and increasing access to the computational pathology solutions coupled with the rising incidents of the chronic diseases such as cancer.
• Major players are employing various strategies such as product launches, collaborations, acquisitions, and mergers to expand their service portfolios and enhance their geographical presence, leading to significant competition within the market. For instance, in February 2023, ClaraPath acquired Crosscope to integrate tissue processing robotics with AI-powered digital pathology, aiming to create the "lab of the future." This combination enhances workflow efficiency by automating tissue processing while leveraging AI technologies for advanced image analysis and diagnostics.

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional scope
  • 1.1.2. Component
  • 1.1.3. Technology
  • 1.1.4. Application
  • 1.1.5. End Use
  • 1.1.6. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Component
  • 2.2.2. Technology
  • 2.2.3. Application
  • 2.2.4. End Use
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Computational Pathology Market Variables, Trends & Scope

• 3.1. Market Dynamics
  • 3.1.1. Market driver analysis
  • 3.1.2. Market restraint analysis
  • 3.1.3. Market Opportunity Analysis
• 3.2. Computational Pathology Market Analysis Tools
  • 3.2.1. Industry Analysis - Porter's
    • 3.2.1.1. Supplier power
    • 3.2.1.2. Buyer power
    • 3.2.1.3. Substitution threat
    • 3.2.1.4. Threat of new entrant
    • 3.2.1.5. Competitive rivalry
  • 3.2.2. PESTEL Analysis
    • 3.2.2.1. Political landscape
    • 3.2.2.2. Economic landscape
    • 3.2.2.3. Social landscape
    • 3.2.2.4. Technological landscape
    • 3.2.2.5. Environmental landscape
    • 3.2.2.6. Legal landscape
  • 3.2.3. Emerging Technology Trends
  • 3.2.4. COVID-19 Impact Analysis
  • 3.2.5. Case Study Analysis

Chapter 4. Computational Pathology Market: Component Estimates & Trend Analysis

• 4.1. Component Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Computational Pathology Market by Component Outlook
• 4.4. Software
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Services
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Computational Pathology Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Computational Pathology Market by Application Outlook
• 5.4. Disease Diagnosis
  • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Drug Discovery & Development
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.6. Academic Research
  • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Computational Pathology Market: Technology Estimates & Trend Analysis

• 6.1. Technology Market Share, 2024 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Computational Pathology Market by Technology Outlook
• 6.4. Machine Learning (ML)
  • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.4.2. Deep Learning
    • 6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.4.3. Others
    • 6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Natural Language Processing (NLP) Models
  • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Computer Vision
  • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Computational Pathology Market: End Use Estimates & Trend Analysis

• 7.1. End Use Market Share, 2024 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Computational Pathology Market by End Use Outlook
• 7.4. Hospitals and Diagnostic Labs
  • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 7.5. Biotechnology and Pharmaceutical Companies
  • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 7.6. Academic and Research Institutes
  • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Computational Pathology Market: Regional Estimates & Trend Analysis, By Component, By Application, By Technology, By End Use

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Norway
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Denmark
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Regulatory framework
    • 8.6.8.3. Competitive scenario
    • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory framework
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Regulatory framework
    • 8.7.6.3. Competitive scenario
    • 8.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Regulatory framework
    • 8.9.1.3. Competitive scenario
    • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Regulatory framework
    • 8.9.2.3. Competitive scenario
    • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Regulatory framework
    • 8.9.3.3. Competitive scenario
    • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Regulatory framework
    • 8.9.4.3. Competitive scenario
    • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Key company market share/position analysis, 2024
• 9.4. Company Profiles
  • 9.4.1. Leica Biosystems Nussloch GmbH (Danaher)
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Hamamatsu Photonics K.K.
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Koninklijke Philips N.V.
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Olympus Corporation
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. F. Hoffmann-La Roche Ltd.
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Mikroscan Technologies, Inc.
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Epredia (3DHISTECH Ltd.)
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Visiopharm A/S
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. Proscia Inc.
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Tempus
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. Huron Technologies International Inc.
    • 9.4.11.1. Company overview
    • 9.4.11.2. Financial performance
    • 9.4.11.3. Product benchmarking
    • 9.4.11.4. Strategic initiatives
  • 9.4.12. ContextVision AB
    • 9.4.12.1. Company overview
    • 9.4.12.2. Financial performance
    • 9.4.12.3. Product benchmarking
    • 9.4.12.4. Strategic initiatives
  • 9.4.13. CellaVision
    • 9.4.13.1. Company overview
    • 9.4.13.2. Financial performance
    • 9.4.13.3. Product benchmarking
    • 9.4.13.4. Strategic initiatives
  • 9.4.14. aetherAI
    • 9.4.14.1. Company overview
    • 9.4.14.2. Financial performance
    • 9.4.14.3. Product benchmarking
    • 9.4.14.4. Strategic initiatives
  • 9.4.15. CellCarta
    • 9.4.15.1. Company overview
    • 9.4.15.2. Financial performance
    • 9.4.15.3. Product benchmarking
    • 9.4.15.4. Strategic initiatives
  • 9.4.16. IBEX (IBEX MEDICAL ANALYTICS)
    • 9.4.16.1. Company overview
    • 9.4.16.2. Financial performance
    • 9.4.16.3. Product benchmarking
    • 9.4.16.4. Strategic initiatives
  • 9.4.17. Nucleai, Inc.
    • 9.4.17.1. Company overview
    • 9.4.17.2. Financial performance
    • 9.4.17.3. Product benchmarking
    • 9.4.17.4. Strategic initiatives